MS

Neurology·MeSH: Consciousness Disorders

Prevalence

287.0 / 100K

Incidence

128.0 / 100K/yr

478 drugs in development·147 companies·1 clinical trial

Drug Pipeline by Phase

Approved(142)

Drug	Company
abrilada	PFIZER INC (PFE)
acetazolamide	Prestige Consumer Healthcare Inc. (PBH)
acetazolamide	Greenwich LifeSciences, Inc. (GLSI)
acetazolamide	ACHIEVE LIFE SCIENCES, INC. (ACHV)
acetazolamide	MANNKIND CORP (MNKD)
acetazolamide	ACADIA PHARMACEUTICALS INC (ACAD)
adcirca	ELI LILLY & Co (LLY)
Alinity® family	ABBOTT LABORATORIES (ABT)
Alinity® family of instruments	ABBOTT LABORATORIES (ABT)
alymsys	Amneal Pharmaceuticals, Inc. (AMRX)
ambrisentan	Mylan II B.V. (MYL)
amjevita	AMGEN INC (AMGN)
amoxicillin	Miromatrix Medical Inc. (MIRO)
Assurity MRI® pacemaker systems	ABBOTT LABORATORIES (ABT)
astepro	Viatris Inc (VTRS)
atomoxetine	Aptinyx Inc. (APTX)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
Aveir® leadless pacemaker systems	ABBOTT LABORATORIES (ABT)
avsola	AMGEN INC (AMGN)
azelastine	Amneal Pharmaceuticals, Inc. (AMRX)
azithromycin	Aptinyx Inc. (APTX)
azithromycin	GT Biopharma, Inc. (GTBP)
azithromycin	SUNSET ISLAND GROUP (SUN)
baclofen	ANI PHARMACEUTICALS INC (ANIP)
baclofen	Impax Laboratories, LLC (IPXL)
bijuva	TherapeuticsMD, Inc. (TXMD)
BRIUMVI	TG THERAPEUTICS, INC. (TGTX)
buspirone	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
cayston	GILEAD SCIENCES, INC. (GILD)
cefepime	Seagen Inc. (SGEN)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
celecoxib	Aptinyx Inc. (APTX)
celecoxib	Zomedica Corp. (ZOMDF)
celecoxib	ACADIA PHARMACEUTICALS INC (ACAD)
celecoxib	Miromatrix Medical Inc. (MIRO)
celecoxib	AlphaTON Capital Corp (ATON)
cetirizine hydrochloride allergy	PERRIGO Co plc (PRGO)
children's cetirizine hydrochloride hives relief	TESARO, Inc. (TSRO)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
Clarithromycin Granules and Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
COTELLIC	EXELIXIS, INC. (EXEL)
credelio quattro	Elanco Animal Health Inc (ELAN)
cromolyn	AGILE THERAPEUTICS INC (AGRX)
cupric	Amneal Pharmaceuticals, Inc. (AMRX)
DEFINITY	Lantheus Holdings, Inc. (LNTH)
desloratadine	PERRIGO Co plc (PRGO)
dextroamp saccharate	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
diclofenac	SUNSET ISLAND GROUP (SUN)
diclofenac	Aptinyx Inc. (APTX)
diclofenac	Miromatrix Medical Inc. (MIRO)
dimethyl	Mylan II B.V. (MYL)
diphenhydramine	Miromatrix Medical Inc. (MIRO)
diphenhydramine	ACHIEVE LIFE SCIENCES, INC. (ACHV)
Double - Coptis Suppository	China Health Industries Holdings, Inc. (CHHE)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
elestrin	Viatris Inc (VTRS)
emblaveo	AbbVie Inc. (ABBV)
epoprostenol	Mylan II B.V. (MYL)
erythromycin lactobionate	NEXUS BIOPHARMA INC (NEXS)
esomeprazole magnesium	LANNETT CO INC (LCI)
esomeprazole magnesium	SUNSET ISLAND GROUP (SUN)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
esomeprazole magnesium	Mylan II B.V. (MYL)
estradiol	Mylan II B.V. (MYL)
estradiol	Amneal Pharmaceuticals, Inc. (AMRX)
exforge hct	Novartis AG (NVS)
fexofenadine	DR REDDYS LABORATORIES LTD (RDY)
fexofenadine	PERRIGO Co plc (PRGO)
fingolimod	Mylan II B.V. (MYL)
fingolimod	DR REDDYS LABORATORIES LTD (RDY)
fingolimod	Teva Pharmaceutical Industries Limited (TEVA)
fingolimod	Aptinyx Inc. (APTX)
fingolimod	GT Biopharma, Inc. (GTBP)
fingolimod	aTYR PHARMA INC (ATYR)
fingolimod	SUNSET ISLAND GROUP (SUN)
fingolimod	ICON plc (ICLR)
firdapse	CATALYST PHARMACEUTICALS, INC. (CPRX)
FIRDAPSE®	CATALYST PHARMACEUTICALS, INC. (CPRX)
FreeStyle® Libre system	ABBOTT LABORATORIES (ABT)
glycopyrrolate	Amneal Pharmaceuticals, Inc. (AMRX)
Hepatocyte Growth-promoting Factor for Injection	CHINA PHARMA HOLDINGS, INC. (CPHI)
hetlioz	Vanda Pharmaceuticals Inc. (VNDA)
imipramine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
iovera°	Pacira BioSciences, Inc. (PCRX)
iovera° system	Pacira BioSciences, Inc. (PCRX)
isoproterenol	Amphastar Pharmaceuticals, Inc. (AMPH)
letairis	GILEAD SCIENCES, INC. (GILD)
levoleucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
loperamide	PERRIGO Co plc (PRGO)
loratadine	PERRIGO Co plc (PRGO)
loratadine redidose	SUNSET ISLAND GROUP (SUN)
lorazepam	ANI PHARMACEUTICALS INC (ANIP)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
loteprednol etabonate	Amneal Pharmaceuticals, Inc. (AMRX)
meloxicam	Mylan II B.V. (MYL)
MIEBO	Bausch Health Companies Inc. (BHC)
minocycline	NEXUS BIOPHARMA INC (NEXS)
naftifine	Amneal Pharmaceuticals, Inc. (AMRX)
nasonex 24hr allergy	PERRIGO Co plc (PRGO)
nebivolol	ANI PHARMACEUTICALS INC (ANIP)
nPulse Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
olmesartan medoxomil	Amneal Pharmaceuticals, Inc. (AMRX)
olopatadine	Amneal Pharmaceuticals, Inc. (AMRX)
orlynvah	Iterum Therapeutics plc (ITRM)
Otrexup	Assertio Holdings, Inc. (ASRT)
Pelvic Inflammation Suppository	China Health Industries Holdings, Inc. (CHHE)
peptide eye repair complex cellular collagen youth serum	REGENEREX PHARMA, INC. (RGPX)
plegridy	BIOGEN INC. (BIIB)
ponvory	Vanda Pharmaceuticals Inc. (VNDA)
propafenone	Mylan II B.V. (MYL)
Purified Cortrophin Gel	ANI PHARMACEUTICALS INC (ANIP)
RYEQO	Myovant Sciences Ltd. (MYOV)
sivextro	Curative Biotechnology Inc (CUBT)
tascenso odt	BICYCLE THERAPEUTICS PLC (BCYC)
telmisartan	Inventiva S.A. (IVA)
teriflunomide	Aptinyx Inc. (APTX)
teriflunomide	Mersana Therapeutics, Inc. (MRSN)
tevimbra	BeOne Medicines Ltd. (ONC)
theophylline	Amneal Pharmaceuticals, Inc. (AMRX)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
toviaz	PFIZER INC (PFE)
treprostinil	Teva Pharmaceutical Industries Limited (TEVA)
triamcinolone acetonide	Aptinyx Inc. (APTX)
triamcinolone acetonide	PERRIGO Co plc (PRGO)
Triamcinolone Acetonide and Neomycin Paste	China Health Industries Holdings, Inc. (CHHE)
trimipramine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Tysabri	Royalty Pharma plc (RPRX)
venlafaxine	Teva Pharmaceutical Industries Limited (TEVA)
vigabatrin	DR REDDYS LABORATORIES LTD (RDY)
VUMERITY	Alkermes plc. (ALKS)
XIENCE® family of drug-eluting coronary stent systems	ABBOTT LABORATORIES (ABT)
XIIDRA	Bausch Health Companies Inc. (BHC)
zaltrap	Sanofi (SNY)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(124)

Drug	Company
177lu-psma-617	Novartis AG (NVS)
177Lu-PSMA-617	Novartis AG (NVS)
5-fu	PFIZER INC (PFE)
abiraterone	CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
abiraterone	GH Research PLC (GHRS)
Abiraterone acetate	Merck & Co., Inc. (MRK)
Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
abp 692	AMGEN INC (AMGN)
adt	Novartis AG (NVS)
Amivantamab	Amneal Pharmaceuticals, Inc. (AMRX)
Amivantamab	REGENXBIO Inc. (RGNX)
Amivantamab and Recombinant Human Hyaluronidase	Amneal Pharmaceuticals, Inc. (AMRX)
ANAVEX®2-73	ANAVEX LIFE SCIENCES CORP. (AVXL)
Androgen-deprivation Therapy	Myovant Sciences Ltd. (MYOV)
Apalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide 60 mg or 240 mg tablets	KYNTRA BIO INC. (KYNB)
Apitox (Apitoxin in South Korea)	Apimeds Pharmaceuticals US, Inc. (APUS)
ardt	Novartis AG (NVS)
ARDT	Novartis AG (NVS)
AZD2962	ASTRAZENECA PLC (AZN)
Belrestotug	iTeos Therapeutics, Inc. (ITOS)
belrestotug (EOS-448/GSK4428859A)	iTeos Therapeutics, Inc. (ITOS)
bezuclastinib (CGT9486)	Cogent Biosciences, Inc. (COGT)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Merck & Co., Inc. (MRK)
Camrelizumab and Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
cetrelimab	GH Research PLC (GHRS)
Cetrelimab	KYNTRA BIO INC. (KYNB)
Cetrelimab	CG Oncology, Inc. (CGON)
cetuximab	GH Research PLC (GHRS)
Cetuximab	REGENXBIO Inc. (RGNX)
Cetuximab	Merck & Co., Inc. (MRK)
Cetuximab	Amneal Pharmaceuticals, Inc. (AMRX)
Conventional NSAA	KYNTRA BIO INC. (KYNB)
Darolutamide	ARS Pharmaceuticals, Inc. (SPRY)
Darolutamide	ELI LILLY & Co (LLY)
Darolutamide	Merus N.V. (MRUS)
dimethyl	BIOGEN INC. (BIIB)
diroximel	BIOGEN INC. (BIIB)
Dostarlimab	iTeos Therapeutics, Inc. (ITOS)
eflornithine plus sulindac	GH Research PLC (GHRS)
eltanexor	Karyopharm Therapeutics Inc. (KPTI)
Enzalutamide	Myovant Sciences Ltd. (MYOV)
Epirubicin	Merck & Co., Inc. (MRK)
Epirubicin	Merus N.V. (MRUS)
Epirubicin Hydrochloride	Merck & Co., Inc. (MRK)
fingolimod	BIOGEN INC. (BIIB)
Fingolimod	Novartis AG (NVS)
Floxuridine	IGM Biosciences, Inc. (IGMS)
Fludrocortisone acetate	Merck & Co., Inc. (MRK)
folfiri	Sanofi (SNY)
folfiri	GH Research PLC (GHRS)
GnRH	ARS Pharmaceuticals, Inc. (SPRY)
GnRH Agonist	Myovant Sciences Ltd. (MYOV)
Hydrocortisone	Merck & Co., Inc. (MRK)
Imlunestrant + Goserelin	ELI LILLY & Co (LLY)
inca033989	Incyte Corp. (INCY)
inca035784	Incyte Corp. (INCY)
inca036978	Incyte Corp. (INCY)
Intismeran autogene	Merck & Co., Inc. (MRK)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
JNJ-56021927	ARS Pharmaceuticals, Inc. (SPRY)
jnj-78278343	GH Research PLC (GHRS)
jnj-86974680	GH Research PLC (GHRS)
jnj-87189401	GH Research PLC (GHRS)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
Leucovorin calcium/Levoleucovorin	REGENXBIO Inc. (RGNX)
LHRHa	Myovant Sciences Ltd. (MYOV)
LHRHA	KYNTRA BIO INC. (KYNB)
LY4064809	ELI LILLY & Co (LLY)
LY4064809	Merus N.V. (MRUS)
MIRV	Merus N.V. (MRUS)
MIRV	ELI LILLY & Co (LLY)
mitomycin c	GH Research PLC (GHRS)
MMC	Merus N.V. (MRUS)
momelotinib	GH Research PLC (GHRS)
New Formulation of Niraparib and Abiraterone Acetate	Janux Therapeutics, Inc. (JANX)
New Formulation of Niraparib and Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
niraparib	TESARO, Inc. (TSRO)
niraparib	GH Research PLC (GHRS)
Niraparib	Janux Therapeutics, Inc. (JANX)
Niraparib	Myovant Sciences Ltd. (MYOV)
ocrelizumab	AMGEN INC (AMGN)
ofatumumab approved dose	Novartis AG (NVS)
Ofatumumab approved dose	Novartis AG (NVS)
ofatumumab new dose	Novartis AG (NVS)
Ofatumumab new dose	Novartis AG (NVS)
Olaparib	Merck & Co., Inc. (MRK)
ONC206	Jazz Pharmaceuticals plc (JAZZ)
Opevesostat	Merck & Co., Inc. (MRK)
orelabrutinib	Zenas BioPharma, Inc. (ZBIO)
ozanimod	CELGENE CORP /DE/ (CELG)
pasritamig	GH Research PLC (GHRS)
Patritumab deruxtecan	Merck & Co., Inc. (MRK)
Pemetrexed	KYNTRA BIO INC. (KYNB)
Pertuzumab	Merck & Co., Inc. (MRK)
Pertuzumab	ASTRAZENECA PLC (AZN)
platinum	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
platinum	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Remzistotug	iTeos Therapeutics, Inc. (ITOS)
roluperidone	Minerva Neurosciences, Inc. (NERV)
Sacituzumab tirumotecan	Merus N.V. (MRUS)
Siponimod	Novartis AG (NVS)
Sofetabart Mipitecan	Merus N.V. (MRUS)
Sofetabart Mipitecan	ELI LILLY & Co (LLY)
solriamfetol	Axsome Therapeutics, Inc. (AXSM)
Standard Adjuvant Endocrine Therapy	PFIZER INC (PFE)
Taletrectinib	Nuvation Bio Inc. (NUVB)
tar-200	GH Research PLC (GHRS)
TAR-200	CG Oncology, Inc. (CGON)
TAR-200	Merus N.V. (MRUS)
tar-210	GH Research PLC (GHRS)
TAR-210	Merus N.V. (MRUS)
Temozolomide	BRISTOL MYERS SQUIBB CO (BMY)
tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	BeOne Medicines Ltd. (ONC)
Tislelizumab	Jazz Pharmaceuticals plc (JAZZ)
tsr-042	TESARO, Inc. (TSRO)
Tucatinib	PFIZER INC (PFE)
Ublituximab	TG THERAPEUTICS, INC. (TGTX)
Ublituximab IV Simplified Dosing Schedule	TG THERAPEUTICS, INC. (TGTX)
Ublituximab Subcutaneous	TG THERAPEUTICS, INC. (TGTX)
Vinblastine	ASTRAZENECA PLC (AZN)

Phase 2(58)

Drug	Company
-endoxifen	ATOSSA THERAPEUTICS, INC. (ATOS)
350 mg leronlimab	CytoDyn Inc. (CYDY)
525 mg leronlimab	CytoDyn Inc. (CYDY)
68ga-psma-11	Novartis AG (NVS)
68Ga-PSMA-11	Novartis AG (NVS)
700 mg leronlimab	CytoDyn Inc. (CYDY)
acer-801	Acer Therapeutics Inc. (ACER)
Adagrasib	Amneal Pharmaceuticals, Inc. (AMRX)
ADT	Novartis AG (NVS)
Apalutamide	ENANTA PHARMACEUTICALS INC (ENTA)
BCG	Merck & Co., Inc. (MRK)
Bezuclastinib	Cogent Biosciences, Inc. (COGT)
biib091	BIOGEN INC. (BIIB)
BMS-986288	CytomX Therapeutics, Inc. (CTMX)
bridging therapy	GH Research PLC (GHRS)
Cabazitaxel	Janux Therapeutics, Inc. (JANX)
Cabozantinib	PTC THERAPEUTICS, INC. (PTCT)
CAR BCMA-CD70-T cells	Filana Therapeutics Inc. (FLNA)
CAR BCMA-CD70-T cells	Merus N.V. (MRUS)
Cetrelimab	Merus N.V. (MRUS)
Cetrelimab	Royalty Pharma plc (RPRX)
cetuximab	PFIZER INC (PFE)
Daratumumab	PTC THERAPEUTICS, INC. (PTCT)
disitamab vedotin	PFIZER INC (PFE)
drf	BIOGEN INC. (BIIB)
Enzalutamide	PTC THERAPEUTICS, INC. (PTCT)
Eribulin	BioNTech SE (BNTX)
Feladilimab	iTeos Therapeutics, Inc. (ITOS)
Flotufolastat F18	Valneva SE (VALN)
GnRH Agonist	Royalty Pharma plc (RPRX)
GnRH Agonist	Janux Therapeutics, Inc. (JANX)
GNRH-A Goserelin	ELI LILLY & Co (LLY)
goserelin	ELI LILLY & Co (LLY)
goserelin	ATOSSA THERAPEUTICS, INC. (ATOS)
GSK4428859A	iTeos Therapeutics, Inc. (ITOS)
GSK6097608	iTeos Therapeutics, Inc. (ITOS)
incb160058	Incyte Corp. (INCY)
Iza-bren	Merus N.V. (MRUS)
JNJ-63723283	Janux Therapeutics, Inc. (JANX)
leucovorin	KYNTRA BIO INC. (KYNB)
morab-202	BRISTOL MYERS SQUIBB CO (BMY)
novel hormonal therapy	PFIZER INC (PFE)
obe-cel	Autolus Therapeutics plc (AUTL)
Oleclumab	ASTRAZENECA PLC (AZN)
pentadecapeptide bpc 157	IO Biotech, Inc. (IOBT)
ph80	Vistagen Therapeutics, Inc. (VTGN)
Ramucirumab	ELI LILLY & Co (LLY)
Ramucirumab	PTC THERAPEUTICS, INC. (PTCT)
Regorafenib	MACROGENICS INC (MGNX)
Regorafinib	PTC THERAPEUTICS, INC. (PTCT)
Relatlimab	PTC THERAPEUTICS, INC. (PTCT)
Rucaparib	PTC THERAPEUTICS, INC. (PTCT)
TAR-200	Janux Therapeutics, Inc. (JANX)
Temozolomide	ELI LILLY & Co (LLY)
topotecan	BRISTOL MYERS SQUIBB CO (BMY)
Trametinib	PTC THERAPEUTICS, INC. (PTCT)
Vinorelbine	PTC THERAPEUTICS, INC. (PTCT)
Vinorelbine	ELI LILLY & Co (LLY)

Phase 1(82)

Drug	Company
[68ga]ga-dwj155	Novartis AG (NVS)
amg 436	AMGEN INC (AMGN)
Ami-HC	Structure Therapeutics Inc. (GPCR)
Ami-HC-CF	Structure Therapeutics Inc. (GPCR)
Ami-LC	Structure Therapeutics Inc. (GPCR)
Ami-LC-MD	Structure Therapeutics Inc. (GPCR)
Apalutamide	Merus N.V. (MRUS)
Apalutamide	Janux Therapeutics, Inc. (JANX)
aza-TdC	Arbutus Biopharma Corp (ABUS)
Belrestotug	ANAPTYSBIO, INC (ANAB)
BI 836845	KYNTRA BIO INC. (KYNB)
Breast cancer vaccine (α-lactalbumin)	Anixa Biosciences Inc (ANIX)
Bridging Therapy	Janux Therapeutics, Inc. (JANX)
CABA-201	Cabaletta Bio, Inc. (CABA)
Cabazitaxel	Myovant Sciences Ltd. (MYOV)
Cabazitaxel	ARS Pharmaceuticals, Inc. (SPRY)
Cabazitaxel	Merus N.V. (MRUS)
Cabazitaxel	Royalty Pharma plc (RPRX)
cetrelimab	JOHNSON & JOHNSON (JNJ)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
Cetrelimab	ARS Pharmaceuticals, Inc. (SPRY)
Cetrelimab	Myovant Sciences Ltd. (MYOV)
Cobolimab	iTeos Therapeutics, Inc. (ITOS)
CUE-102	Cue Biopharma, Inc. (CUE)
E7389-LF	ENANTA PHARMACEUTICALS INC (ENTA)
elacestrant	STEMLINE THERAPEUTICS INC (STML)
enfortumab vedotin	ELI LILLY & Co (LLY)
Enzalutamide	Janux Therapeutics, Inc. (JANX)
felmetatug vedotin	PFIZER INC (PFE)
GSK4418959	IDEAYA Biosciences, Inc. (IDYA)
GSK5764227	KYNTRA BIO INC. (KYNB)
GSK6097608	ANAPTYSBIO, INC (ANAB)
hdp-101	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
hdp-101	NYMOX PHARMACEUTICAL CORP (NYMXF)
hro761	NOVARTIS AG (NVSEF)
hro761	Novartis AG (NVS)
IDE275 (GSK959)	IDEAYA Biosciences, Inc. (IDYA)
idrx-42	GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)
Imlunestrant	ELI LILLY & Co (LLY)
jnj-101556143	GH Research PLC (GHRS)
jnj-1761981	JOHNSON & JOHNSON (JNJ)
jnj-1761981	Innovation Pharmaceuticals Inc. (IPIX)
jnj-69086420	GH Research PLC (GHRS)
jnj-75229414	GH Research PLC (GHRS)
JNJ-75229414	Filana Therapeutics Inc. (FLNA)
JNJ-75229414	Janux Therapeutics, Inc. (JANX)
JNJ-75229414	Merus N.V. (MRUS)
JNJ-75229414	KYNTRA BIO INC. (KYNB)
JNJ-78278343	ARS Pharmaceuticals, Inc. (SPRY)
JNJ-78278343	KYNTRA BIO INC. (KYNB)
JNJ-78278343	Myovant Sciences Ltd. (MYOV)
JNJ-78278343	Merus N.V. (MRUS)
JNJ-78278343	Janux Therapeutics, Inc. (JANX)
JNJ-78278343	Royalty Pharma plc (RPRX)
jnj-87704916	Innovation Pharmaceuticals Inc. (IPIX)
jnj-87704916	JOHNSON & JOHNSON (JNJ)
JNJ-87704916	Janux Therapeutics, Inc. (JANX)
jnj-88549968	GH Research PLC (GHRS)
jnj-89402638	GH Research PLC (GHRS)
jnj-95298177	GH Research PLC (GHRS)
JNJ-95298177	Janux Therapeutics, Inc. (JANX)
jnj-95437446	GH Research PLC (GHRS)
jnj-95804306	GH Research PLC (GHRS)
leucovorin	PFIZER INC (PFE)
LHRH agonist/antagonist	ELI LILLY & Co (LLY)
loxo-435	ELI LILLY & Co (LLY)
ly3484356	ELI LILLY & Co (LLY)
LY4214835	ELI LILLY & Co (LLY)
LY4257496	ELI LILLY & Co (LLY)
LY4337713	ELI LILLY & Co (LLY)
PD-1 inhibitor	IDEAYA Biosciences, Inc. (IDYA)
pf-08046050	PFIZER INC (PFE)
pf-08046052	PFIZER INC (PFE)
prn2246/sar442168	Principia Biopharma Inc. (PRNB)
Pumitamig	Merus N.V. (MRUS)
QLH12016	KYNTRA BIO INC. (KYNB)
rese-cel (resecabtagene autoleucel)	Cabaletta Bio, Inc. (CABA)
standard disease-directed therapy	Incyte Corp. (INCY)
TdCyd	Arbutus Biopharma Corp (ABUS)
Topotecan	ELI LILLY & Co (LLY)
Tucatinib	Merck & Co., Inc. (MRK)
TVB-2640	KYNTRA BIO INC. (KYNB)

Preclinical(15)

Drug	Company
aav.104	Decibel Therapeutics, Inc. (DBTX)
activated cannabinoid	Phoenix Life Sciences International Limited. (PLSI)
Additional discovery and early preclinical programs	Scholar Rock Holding Corp (SRRK)
apitox	Apimeds Pharmaceuticals US, Inc. (APUS)
cpi-482	CONSTELLATION PHARMACEUTICALS INC (CNST)
ec2629	ENDOCYTE INC (ECYT)
ht-kit	Hoth Therapeutics, Inc. (HOTH)
JAK2 program	Cogent Biosciences, Inc. (COGT)
labp-66	Landos Biopharma, Inc. (LABP)
prana bio nutrient medicinals	UNITED CANNABIS CORP (CNAB)
rpi-78m	NUTRA PHARMA CORP (NPHC)
sc379	Sana Biotechnology, Inc. (SANA)
small molecule fyn kinase inhibitor	NEXUS BIOPHARMA INC (NEXS)
Small molecule IFNAR agonist program	ASSEMBLY BIOSCIENCES, INC. (ASMB)
stat-203	Statera Biopharma, Inc. (CBLI)

Unknown(19)

Drug	Company
Abiraterone acetate	Janux Therapeutics, Inc. (JANX)
AiroPro	Ascend Wellness Holdings, Inc. (AAWH)
apj agonist program	BioAge Labs, Inc. (BIOA)
Assurity MRI® and Endurity MRI® pacemaker systems	ABBOTT LABORATORIES (ABT)
DARE-HRT1	Dare Bioscience, Inc. (DARE)
et mono ± lhrh	NOVARTIS AG (NVSEF)
et mono ± lhrh	Novartis AG (NVS)
Heptral™	ABBOTT LABORATORIES (ABT)
i-STAT® and i-STAT® Alinity®	ABBOTT LABORATORIES (ABT)
interfyl	Celularity Inc. (CELU)
iPScelz™ (iPSC program)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
KRM Chromatography Systems	REPLIGEN CORP (RGEN)
Novel MS therapeutic target (discovery)	Adaptive Biotechnologies Corp (ADPT)
Pluripain PMS™	BIOADAPTIVES, INC. (BDPT)
PluriPain-PMS	BIOADAPTIVES, INC. (BDPT)
PluriPain®	BIOADAPTIVES, INC. (BDPT)
Samyr™	ABBOTT LABORATORIES (ABT)
SJ02	Organon & Co. (OGN)
Transmetil™	ABBOTT LABORATORIES (ABT)

N/A(1)

Drug	Company
GLP-1 receptor agonist	ELI LILLY & Co (LLY)

Phase 1/Phase 2(13)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
ABCL635	AbCellera Biologics Inc. (ABCL)
CRN09682	Crinetics Pharmaceuticals, Inc. (CRNX)
dare to reclaim	Dare Bioscience, Inc. (DARE)
dazostinag	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
dazostinag	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Enzalutamide	Arcus Biosciences, Inc. (RCUS)
jnj-63723283	GH Research PLC (GHRS)
lx2021	Lexeo Therapeutics, Inc. (LXEO)
modakafusp alfa	Teva Pharmaceutical Industries Limited (TEVA)
nenocorilant	CORCEPT THERAPEUTICS INC (CORT)
Pumitamig	BioNTech SE (BNTX)
tisotumab vedotin	PFIZER INC (PFE)

Phase 2/Phase 3(4)

Drug	Company
[18f]ctt1057	Novartis AG (NVS)
Actimab-A	Actinium Pharmaceuticals, Inc. (ATNM)
granite	Gritstone bio, Inc. (GRTS)
iza-bren	BRISTOL MYERS SQUIBB CO (BMY)

Phase 4(20)

Drug	Company
abiraterone	PFIZER INC (PFE)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
androgen deprivation therapy	GH Research PLC (GHRS)
Androgen receptor inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Pathway Inhibitors	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signal Inhibitor	KYNTRA BIO INC. (KYNB)
Androgen Receptor Signalling Inhibitor	KYNTRA BIO INC. (KYNB)
androgen-deprivation therapy	GH Research PLC (GHRS)
Androgen-deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Apalutamide	KYNTRA BIO INC. (KYNB)
Bicalutamide	KYNTRA BIO INC. (KYNB)
bms-986213	BRISTOL MYERS SQUIBB CO (BMY)
Darolutamide	KYNTRA BIO INC. (KYNB)
Dexmedetomidine Injection [Precedex]	COGNITION THERAPEUTICS INC (CGTX)
Enzalutamide	Royalty Pharma plc (RPRX)
fingolimod	Novartis AG (NVS)
Relatlimab	BRISTOL MYERS SQUIBB CO (BMY)
Xeloda	IGM Biosciences, Inc. (IGMS)

Compare drugs

abrilada vs acetazolamide abrilada vs adcirca abrilada vs Alinity® family

Frequently asked questions

How many drugs are in development for MS?

BioSniper tracks 478 drugs in development for MS across 147 companies.

How many clinical trials target MS?

There are 1 clinical trial targeting MS tracked by BioSniper.

What is the prevalence of MS?

The estimated prevalence of MS is approximately 287.0 per 100,000 population.

Deep-dive into MS

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis